UBS Raises Price Target on Albemarle (ALB) to $85 Following 3Q Report

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/23/2026

1. KBH
2. PATH
3. SPY
4. USO
5. AZO
6. RCL
7. ONON
8. PLTR
9. QQQ
10. PRGS

Go back to UBS Raises Price Target on Albemarle (ALB) to $85 Following 3Q Report

Albemarle (ALB) Announces Election of New Board Chairman

November 8, 2016 6:27 AM EST

The board of directors of Albemarle Corporation (NYSE: ALB) announced its decision to elect president and chief executive officer, Luke Kissam, as chairman, effective November 7, 2016. He assumes this title in... More

Albemarle (ALB) Tops Q3 EPS by 10c, Updates FY Guidance

November 7, 2016 5:36 PM EST

Albemarle (NYSE: ALB) reported Q3 EPS of $0.91, $0.10 better than the analyst estimate of $0.81. Revenue for the quarter came in at $654 million versus the consensus estimate of $645.81 million.

GUIDANCE:

Albemarle sees Q4 2016 EPS of $3.45-$3.55, versus the consensus of $3.48. Albemarle sees Q4... More

Trading Radar for 11/7: MGM Resorts (MGM), LendingClub (LC), Dean Foods (DF), Ferrari (RACE), Sysco (SYY) Report

November 4, 2016 3:49 PM EDT

The Trading Radar highlights key earnings and economic announcements for the next trading session:

Before Markets Open:
Earnings:

ARIAD Pharma (Nasdaq: ARIA) - consensus loss $0.19
Altisource Residential (Nasdaq: RESI) - consensus loss $0.48
Amicus Therapeutics (Nasdaq: FOLD) - consensus loss $0.34
ArQule (Nasdaq: ARQL) - consensus loss $0.09
Aralez Pharma (Nasdaq: ARLZ) - consensus loss $0.37
Ardelyx (Nasdaq: ARDX) -... More